Benoit Samson-Couterie
Papers
1
Total Citations
1
H-Index
1
About
Benoit Samson-Couterie is a pioneering researcher in cardiovascular pharmacology and stem cell biology, whose work focuses on leveraging human induced pluripotent stem cell (hiPSC) technology to model inherited cardiac arrhythmias and accelerate drug discovery. His most notable contribution is the development of high-throughput drug screening platforms using three-dimensional hiPSC-derived cardiac microtissues, which recapitulate the complex pathophysiology of disorders such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. This innovative approach, detailed in his 2025 study, enables the identification of novel therapeutic compounds with greater physiological relevance than traditional 2D cultures, bridging the gap between preclinical models and clinical efficacy. Though early in its citation trajectory, this work has already garnered attention for its potential to transform personalized medicine and reduce reliance on animal testing. Samson-Couterie’s research is distinguished by its integration of bioengineering, electrophysiology, and pharmacology, offering a powerful tool for screening cardiotoxicity and rare disease treatments. His achievements underscore a commitment to translating fundamental stem cell science into tangible therapeutic solutions for patients with life-threatening heart conditions.
Research Focus
Key Achievements
Top Papers
- 1